{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:40:09Z","timestamp":1756662009767,"version":"3.44.0"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020282","name":"Faucett Catalyst Fund","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100020282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40119C10054"],"award-info":[{"award-number":["75F40119C10054"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2023,10,18]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is an urgent need to investigate the capabilities of active surveillance in strengthening the development of pharmacovigilance (PV) systems in low-resource settings. Here, we assess the capability and feasibility of prospectively collected data to document maternal immunisation and adverse birth outcomes across delivery centres in Kinshasa, Democratic Republic of the Congo (DRC) according to the Global Alignment of Immunisation Safety Assessment in pregnancy (GAIA) definitions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a facility-based prospective cohort study that enrolled mothers via convenience sampling either during their antenatal care visit or following their delivery. Demographic and clinical information as well as postpartum details related to the index pregnancy were collected after delivery; all mothers were also contacted via telephone 30 days postdelivery to determine if certain outcomes occurred after health facility discharge. Adverse birth outcomes of interest and maternal tetanus immunisation were categorised according to the GAIA criteria, and the level and impact of loss to follow-up (LTFU) was also evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study population consisted of 2675 mothers. The proportion of adverse birth outcomes ranged from 1.6% (for neonatal death) to 15.8% (for small for gestational age). Evidence of maternal tetanus immunisation during the index pregnancy was found for 637 mothers of newborns with any adverse birth outcome. GAIA diagnostic certainty was high for low birth weight and preterm birth, but much lower for stillbirth and neonatal bloodstream infections. Additionally, LTFU was high: only 47.9% of all mothers were successfully followed up via phone call.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our investigation highlighted some of the challenges associated with the utilisation of the GAIA criteria in (prospective) observational studies within health facilities in Kinshasa, DRC (eg, data quality, LTFU and selection bias). Nevertheless, active surveillance remains a promising tool for future PV activities in DRC and beyond.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjph-2023-000035","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T12:08:38Z","timestamp":1699963718000},"page":"e000035","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Capability and feasibility of the Global Alignment of Immunisation Safety Assessment in pregnancy criteria for the assessment of pregnancy and birth outcomes in Kinshasa, Democratic Republic of the Congo: a prospective cohort study"],"prefix":"10.1136","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-771X","authenticated-orcid":false,"given":"Patrick J","family":"Arena","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adva","family":"Gadoth","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalau Mukadi","family":"Nkamba","sequence":"additional","affiliation":[{"name":"Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Dzogang","sequence":"additional","affiliation":[{"name":"UCLA-DRC Health Research and Training Program, Kinshasa, Democratic Republic of the Congo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1770-6304","authenticated-orcid":false,"given":"Nicole","family":"Hoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica L","family":"Barrall","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kampilu","sequence":"additional","affiliation":[{"name":"UCLA-DRC Health Research and Training Program, Kinshasa, Democratic Republic of the Congo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beia","sequence":"additional","affiliation":[{"name":"UCLA-DRC Health Research and Training Program, Kinshasa, Democratic Republic of the Congo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lee","family":"Wong","sequence":"additional","affiliation":[{"name":"Office of Biostatistics and Pharmacovigilance, US Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Anderson","sequence":"additional","affiliation":[{"name":"Office of Biostatistics and Pharmacovigilance, US Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didine","family":"Kaba","sequence":"additional","affiliation":[{"name":"Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of the Congo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne W","family":"Rimoin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Public Health, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"2025083110151963000_1.1.e000035.1","doi-asserted-by":"crossref","unstructured":"Strom BL , Kimmel SE , Hennessy S . What is pharmacoepidemiology? . In: Pharmacoepidemiology. John Wiley & Sons, Ltd, 2019: 1\u201326. doi:10.1002\/9781119413431","DOI":"10.1002\/9781119413431.ch1"},{"key":"2025083110151963000_1.1.e000035.2","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1053391"},{"key":"2025083110151963000_1.1.e000035.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-018-0431-0"},{"key":"2025083110151963000_1.1.e000035.4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11096-017-0570-z","article-title":"Pharmacovigilance in developing countries (part I): importance and challenges","volume":"40","author":"Elshafie","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"2025083110151963000_1.1.e000035.5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s11096-017-0588-2","article-title":"Pharmacovigilance in developing countries (part II): a path forward","volume":"40","author":"Elshafie","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"2025083110151963000_1.1.e000035.6","doi-asserted-by":"crossref","unstructured":"Nzolo D , Kuemmerle A , Lula Y , et al . Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo. Ther Adv Drug Saf 2019;10. doi:10.1177\/2042098619864853","DOI":"10.1177\/2042098619864853"},{"key":"2025083110151963000_1.1.e000035.7","unstructured":"World Health Organization . Active surveillance. Available: https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance\/health-professionals-info\/active-surveillance [Accessed 16 Jul 2022]."},{"key":"2025083110151963000_1.1.e000035.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1509044"},{"key":"2025083110151963000_1.1.e000035.9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41372-020-0668-3","article-title":"Closer and closer? Maternal immunization: current promise, future horizons","volume":"40","author":"Engmann","year":"2020","journal-title":"J Perinatol"},{"key":"2025083110151963000_1.1.e000035.10","unstructured":"World Health Organization . Maternal immunization and antenatal care service delivery situation analysis: report of the MIACSA project, 2016-2019, . 2020 Available: https:\/\/www.who.int\/publications\/i\/item\/9789240004016"},{"key":"2025083110151963000_1.1.e000035.11","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2018.09.033","article-title":"Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: a feasibility assessment","volume":"36","author":"Stuurman","year":"2018","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.12","unstructured":"Meyer A . Safe in pregnancy. Available: https:\/\/safeinpregnancy.org\/ [Accessed 2 May 2022]."},{"key":"2025083110151963000_1.1.e000035.13","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy - the GAIA project","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.14","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.vaccine.2022.04.073","article-title":"Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa, Democratic Republic of the Congo","volume":"40","author":"Gadoth","year":"2022","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12884-022-05291-w","article-title":"Comparison of adverse pregnancy and birth outcomes using Archival medical records before and during the first wave of the COVID-19 pandemic in Kinshasa, democratic Republic of Congo: a facility-based, retrospective cohort study","volume":"23","author":"Arena","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025083110151963000_1.1.e000035.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060929","article-title":"Adherence to face mask use during the COVID-19 pandemic among women seeking Antenatal care in Kinshasa, democratic Republic of Congo: a facility-based cross-sectional study","volume":"12","author":"Nkamba","year":"2022","journal-title":"BMJ Open"},{"issue":"48 Pt A","key":"2025083110151963000_1.1.e000035.17","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2017.01.044","article-title":"Congenital Microcephaly: case definition & guidelines for data collection, analysis, and presentation of safety data after maternal Immunisation","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.045"},{"key":"2025083110151963000_1.1.e000035.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.045"},{"key":"2025083110151963000_1.1.e000035.20","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1016\/j.vaccine.2017.01.040","article-title":"Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data","volume":"35","author":"Schlaudecker","year":"2017","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.049"},{"key":"2025083110151963000_1.1.e000035.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.040"},{"key":"2025083110151963000_1.1.e000035.23","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1016\/j.vaccine.2016.03.046","article-title":"Neonatal infections: case definition and guidelines for data collection, analysis, and presentation of Immunisation safety data","volume":"34","author":"Vergnano","year":"2016","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/inthealth\/ihy066","article-title":"Assessing feasibility of resources at health facilities in Uganda to diagnose pregnancy and neonatal outcomes","volume":"11","author":"Stark","year":"2019","journal-title":"Int Health"},{"key":"2025083110151963000_1.1.e000035.25","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2019.03.074","article-title":"Immunization in pregnancy safety surveillance in low and middle-income Countries- field performance and validation of novel case definitions","volume":"37","author":"Kochhar","year":"2019","journal-title":"Vaccine"},{"key":"2025083110151963000_1.1.e000035.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100123","article-title":"WHO global vaccine safety multi-country collaboration project on safety in pregnancy: assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization","volume":"9","author":"Stuurman","year":"2021","journal-title":"Vaccine X"},{"key":"2025083110151963000_1.1.e000035.27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/INF.0000000000003261","article-title":"Applicability of the GAIA maternal and neonatal outcome case definitions for the evaluation of adverse events following vaccination in pregnancy in high-income countries","volume":"40","author":"Watson","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2025083110151963000_1.1.e000035.28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11904-016-0335-7","article-title":"Community-based ART programs: sustaining adherence and follow-up","volume":"13","author":"Mukherjee","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025083110151963000_1.1.e000035.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.08.003"},{"key":"2025083110151963000_1.1.e000035.30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12913-020-05436-7","article-title":"Home visits by community health workers in rural South Africa have a limited, but important impact on maternal and child health in the first two years of life","volume":"20","author":"Stansert Katzen","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2025083110151963000_1.1.e000035.31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5334\/aogh.3019","article-title":"Early experiences in the integration of non-communicable diseases into emergency primary health care, Beni region, Democratic Republic of the Congo","volume":"87","author":"Ratnayake","year":"2021","journal-title":"Ann Glob Health"},{"key":"2025083110151963000_1.1.e000035.32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12913-015-1176-6","article-title":"Social accountability for maternal health services in Muanda and Bolenge health zones, Democratic Republic of Congo: a situation analysis","volume":"15","author":"Mafuta","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"2025083110151963000_1.1.e000035.33","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1089\/hs.2019.0065","article-title":"Lessons learned from reinforcing epidemiologic surveillance during the 2017 Ebola outbreak in the Likati district, Democratic Republic of the Congo","volume":"18","author":"Hemingway-Foday","year":"2020","journal-title":"Health Secur"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2023-000035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:15:28Z","timestamp":1756660528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2023-000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,14]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjph-2023-000035"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2023-000035","relation":{},"ISSN":["2753-4294"],"issn-type":[{"type":"electronic","value":"2753-4294"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}